Top news
FDA panel recommends molnupiravir, first pill for COVID-19
By Stephanie Soucheray
How the New Antiviral Pills Help Thwart COVID
By Stephani Sutherland
US panel backs first-of-a-kind COVID-19 pill from Merck
By Matthew Perrone
All coverage
FDA advisory panel narrowly recommends Merck’s Covid pill for emergency use
By Berkeley Lovelace & Berkeley Lovelace Jr.
FDA panel narrowly recommends authorization of first antiviral pill to treat Covid-19
By Matthew Herper
U.S. FDA panel narrowly backs Merck's at-home COVID-19 pill
By Michael Erman & Manas Mishra
FDA advisory panel narrowly endorses Merck's oral Covid treatment pill, despite reduced efficacy and safety questions
By Spencer Kimball
FDA advisers vote to recommend authorization of a pill to treat Covid-19
By Maggie Fox & Jen Christensen
Merck's Covid Treatment Pill Wins Blessing of F.D.A. Panel (Published 2021)
By Rebecca Robbins & Carl Zimmer